Agrylin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Anagrelide Hydrochloride.
| Product ID | 54092-063_2e8a557f-0338-47ff-9ba8-ff4bbf193d1b |
| NDC | 54092-063 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Agrylin |
| Generic Name | Anagrelide Hydrochloride |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 1997-03-14 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020333 |
| Labeler Name | Takeda Pharmaceuticals America, Inc. |
| Substance Name | ANAGRELIDE HYDROCHLORIDE |
| Active Ingredient Strength | 1 mg/1 |
| Pharm Classes | Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 1997-03-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020333 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1997-03-14 |
| Ingredient | Strength |
|---|---|
| ANAGRELIDE HYDROCHLORIDE | .5 mg/1 |
| SPL SET ID: | cb960074-99c1-4a73-941f-f0644a7ec219 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 54092-063 | Agrylin | anagrelide hydrochloride |
| 0172-5240 | Anagrelide Hydrochloride | Anagrelide Hydrochloride |
| 0172-5241 | Anagrelide Hydrochloride | Anagrelide Hydrochloride |
| 68151-2959 | Anagrelide Hydrochloride | Anagrelide Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AGRYLIN 78609806 3119751 Live/Registered |
Shire LLC 2005-04-15 |
![]() AGRYLIN 75195604 2160991 Dead/Cancelled |
SHIRE LLC 1996-11-12 |